INTRODUCTION AND OBJECTIVE:GLP1 agonists (GLP1a), including semaglutide and tirzepatide, were initially developed for diabetes mellitus (DM) management but are increasingly used for obesity. Female factor infertility has been found to improve after …
Benign prostatic hyperplasia (BPH) is the most common urological condition, often associated with lower urinary tract symptoms impacting quality of life. It is estimated to…
Anemia is prevalent among patient starting hemodialysis after end-stage kidney disease, and it is tied with major cardiovascular events.
Panelists discuss how non–muscle-invasive bladder cancer (NMIBC) is staged, graded, and treated according to risk stratification, with detailed explanations of low-, intermediate-, and high-risk categories…
Results from the phase 3 AMPLIFY trial are intended to support an application to the FDA for potential approval of 64Cu-SAR-bisPSMA.
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
“Appropriate patient selection for CN is a highly individualized process that is improved with a multidisciplinary approach,” write the authors.
A study compared postoperative outcomes of laser surgery vs TURP for benign prostatic hyperplasia in patients with various stages of chronic kidney disease.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
According to Adam B. Weiner, MD, a urologist at Cedars-Sinai Medical Center, men should begin prostate cancer screening around ages 50 to 55.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
